Gabexate Mesilate (Foy^®) as an Anticoagulant in Extracorporeal Circulation in Dogs and Sheep

Summary

Gabexate mesilate (GM), a synthetic serine protease inhibitor with a short half-life time of approx. 80 sec, was applied as the exclusive anticoagulant in small scale extracorporeal circulation in narcotized dogs and sheep. The animals underwent a veno-venous bypass. As the blood was drawn out of the femoral vein, GM was infused immediately into the extracorporeal system. GM was greatly reduced because of its short half-life time before the blood reentered the animal via a brachial vein. In order to control the coagulatory state of the blood, the Activated Clotting Time (ACT), Partial Thromboplastine Time (PTT) and Recalcification Time (RT) were measured in regular intervals. In addition, a screen pressure test device was used to monitor on line during ECC the tendency of blood clotting. It was shown that the blood of the extracorporeal system was sufficiently anticoagulated by an infusion of 0.03 mg/ml/min GM. During two hours ECC, simultaneously measured ACT - values of the animals only differed up to 10 percent from the native values. Pilot studies have shown that the results of these model investigations could be successfully transferred to extracorporeal circulation with membrane oxygenators and pumps as they are clinically used.

Key words

Gabexate mesilate - Extracorporeal circulation - Screen pressure

• References

• 1 Saitoh Y. Review of clinical results with gabexate mesilate (FOY) in Japan. In: Proteinasen-Inhibition, FOY-Workshop Düsseldorf 1981. Grözinger K-H, Schrey A, Wabnitz RW. (Eds) Universitätsdruckerei und Verlag Dr. C Wolf & Sohn; München FRG: 1982. pp 108-122
• 2 Ohno H, Kambayashi J, Chang SW, Kosaki G. FOY: [Ethyl-p-(6- guanidino-hexanoyloxy) benzoate] methanesulfonate as a serine proteinase inhibitor. II. In vivo effect on coagulo-fibrinolytic system in comparison with heparin or aprotinin. Thromb Res 1981; 24: 445-452
• 3 Stemberger A, Stöhr R, Asherl R, Wendt P, Haas S, Blümel G. Einfluß von FOY auf die Proteolyse-Meachnismen von Gerinnung und Fibrinolyse. In: Proteasen-Inhibition, FOY-Workshop Düsseldorf 1981. Grözinger K-H, Schrey A, Wabnitz RW. (Eds) Universitätsdruckerei und Verlag Dr. C. Wolf & Sohn; München FRG: 1982. pp 203-214
• 4 Noack E. Pharmakologische Grundlagen zur therapeutischen Anwendbarkeit von Gabexat Mesilat (FOY). In: Proteasen-Inhibition, FOY-Workshop Düsseldorf 1981. Grözinger K-H, Schrey A, Wabnitz RW. (Eds) Universitätsdruckerei und Verlag Dr. C Wolf & Sohn; München FRG: 1982. pp 44-56
• 5 Bruhn HD. Niedrig dosiertes Heparin (low dose heparin) Wirkungsweise und Indikationen. Schattauer; Stuttgart - New York: 1980. 2 36-39
• 6 Kakkar VV. Antithrombin-III - ein wichtiger Parameter in der klinischen Chemie. Diagnostica Dialog. Boehringer Mannheim GmbH; 1981. 1 1-3
• 7 Bey R, Mottaghy K, Oedekoven B, Schmid-Schönbein H. Reduction of heparin in extracorporeal circulations (ECC) in small animals applying different protacyclin. Proceedings Europ Soc Artif Organs. Belenger J. (Ed) Saunders Company; London: 1982. 9 153-156
• 8 Eika C, Godal HC. Thrombocytopenia in rabbits induced by heparin, protamine and polybrene. Scand J Haematol 1971; 8: 481-486
• 9 Godal HC. Thrombocytopenia and heparin. Thromb Haemostas 1980; 43: 222-224
• 10 Bruhn HD. Niedrig dosiertes Heparin (low dose heparin) Wirkungsweise und Indikationen. Schattauer; Stuttgart - New York: 1980. 2 36-39
• 11 Jack A. Use of activated clotting time to monitor heparin during cardiac surgery. Ann Thorac Surg 1979; 28: 69-72
• 12 Swank RL, Roth JG, Jansen J. Screen filtration pressure method and adhesiveness and aggregation of blood cells. J Appl Physiol 1964; 19: 340-346
• 13 Swank RL. Alteration of blood on storage: measurement of adhesiveness of “aging” platelets and leucocytes and their removal by filtration. N Engl J Med 1961; 265: 728-733
• 14 Swank RL, Hirsch H, Isselhard W. Continuous filtration of blood through pyrex glass wool filters. 2nd Europ Conf Microcirculation, Pavia 1962 Bibl Anat 1964; 4: 62-71
• 15 Lester A, Mottaghy K, Mussler K. Ein Monitoring-System zur Anzeige und Überwachung von Vitalparametem und anderen Meßwerten während extrakorporaler Zirkulation. Biomed Technik 1983; 28: 29